Hainan Aike Pharmaceutical

Hainan Aike Pharmaceutical is a Chinese pharmaceutical company established in 2002 and based in Haikou, Hainan. The company specializes in the research, development, and large-scale manufacturing of antibacterial drugs, with a particular focus on high-end infusion and injection formulations. Its flagship products include Etimicin Sulfate Sodium Chloride Injection (marketed as Aiyi) and Moxifloxacin Hydrochloride Sodium Chloride Injection, both of which hold significant market shares in China's aminoglycoside and fluoroquinolone sectors. Hainan Aike operates advanced GMP-certified production lines for glass bottle infusions, non-PVC soft bag infusions, and small-volume injections. The company is currently expanding its pipeline into innovative drugs and biopharmaceuticals to diversify its therapeutic offerings beyond traditional antibiotics.